SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-24-001121 to THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. (TSOI) (CIK 0001419051)

THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. (TSOI) (CIK 0001419051)
Date: Jan. 30, 2024 · CIK: 0001419051 · Accession: 0000000000-24-001121

AI Filing Summary & Sentiment

File numbers found in text: 333-276559

Date
January 29, 2024
Author
Not clearly detected
Form
UPLOAD
Company
THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. (TSOI) (CIK 0001419051)

Letter

United States securities and exchange commission logo January 29, 2024 Timothy G. Dixon Chief Executive Officer Therapeutic Solutions International, Inc. 701 Wild Rose Lane Elk City, Idaho 83525 Re:Therapeutic Solutions International, Inc. Registration Statement on Form S-1 Filed January 17, 2024 File No. 333-276559 Dear Timothy G. Dixon: We have conducted a limited review of your registration statement and have the following comment(s). Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe a comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your registration statement and the information you provide in response to this letter, we may have additional comments. Registration Statement on Form S-1 filed January 17, 2024 Executive Compensation, page 43 1.Please include executive compensation disclosure for your executive officers for the fiscal year ended December 31, 2023. For guidance, please refer to Item 402 of Regulation S- K and Question 117.05 of the Compliance & Disclosure Interpretations for Regulation S-K. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Refer to Rules 460 and 461 regarding requests for acceleration. Please allow adequate time for us to review any amendment prior to the requested effective date of the registration statement. Please contact Conlon Danberg at 202-551-4466 or Jessica Ansart at 202-551-4511 with

FirstName LastNameTimothy G. Dixon Comapany NameTherapeutic Solutions International, Inc. January 29, 2024 Page 2 FirstName LastName Timothy G. Dixon Therapeutic Solutions International, Inc. January 29, 2024 Page 2 any other questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Hugh Kelso, Esq.

Show Raw Text
United States securities and exchange commission logo
January 29, 2024
Timothy G. Dixon
Chief Executive Officer
Therapeutic Solutions International, Inc.
701 Wild Rose Lane
Elk City, Idaho 83525
Re:Therapeutic Solutions International, Inc.
Registration Statement on Form S-1
Filed January 17, 2024
File No. 333-276559
Dear Timothy G. Dixon:
            We have conducted a limited review of your registration statement and have the
following comment(s).
            Please respond to this letter by amending your registration statement and providing the
requested information. If you do not believe a comment applies to your facts and circumstances
or do not believe an amendment is appropriate, please tell us why in your response.
            After reviewing any amendment to your registration statement and the information you
provide in response to this letter, we may have additional comments.
Registration Statement on Form S-1 filed January 17, 2024
Executive Compensation, page 43
1.Please include executive compensation disclosure for your executive officers for the fiscal
year ended December 31, 2023. For guidance, please refer to Item 402 of Regulation S- K
and Question 117.05 of the Compliance & Disclosure Interpretations for Regulation S-K.
            We remind you that the company and its management are responsible for the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action or absence of
action by the staff.
            Refer to Rules 460 and 461 regarding requests for acceleration. Please allow adequate
time for us to review any amendment prior to the requested effective date of the registration
statement.
            Please contact Conlon Danberg at 202-551-4466 or Jessica Ansart at 202-551-4511 with

 FirstName LastNameTimothy G. Dixon
 Comapany NameTherapeutic Solutions International, Inc.
 January 29, 2024 Page 2
 FirstName LastName
Timothy G. Dixon
Therapeutic Solutions International, Inc.
January 29, 2024
Page 2
any other questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc:       Hugh Kelso, Esq.